首页 文献索引 SCI期刊 AI助手
条件筛选
相关性 最新发表 最早发表
全文 标题 期刊 作者
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
模糊 精准
{{tag.shortname||tag.name}}:{{getFilterLabel(field)}} Clear All
Hongjin Li,Jianke Lyu,Yu Sun et al. Hongjin Li et al.
Our study highlights the therapeutic potential of targeting the ZDHHC13-E-cadherin axis and its downstream metabolic and immune-modulatory mechanisms, offering additional strategies to inhibit melanoma progression and metastasis.
Somlata Khamaru,Kshyama Subhadarsini Tung,Subhasis Chattopadhyay Somlata Khamaru
These findings suggest that targeting NRP1 could slow melanoma progression and reduce peripheral Treg-mediated immunosuppression, making it a promising approach for future cancer immunotherapies, especially in combination with other treatments.
Huayu Huang,Dong Li,Yichuan Li et al. Huayu Huang et al.
Background: N6-methyladenosine (m6A) modification plays a crucial role in tumor biology; however, the function of the methyltransferase adaptor WTAP in melanoma remains poorly understood. Methods: We analyzed WTAP expression and its clinica...
Fengyi Mao,Sai Wu,Derek B Allison et al. Fengyi Mao et al.
Polo-like kinase 1 (PLK1), a critical cell cycle regulator, is associated with cancer progression and negatively correlates with patient survival in cutaneous melanoma based on clinical database analysis. In a melanoma mouse model induced b...
Xiaoqiang Liu,Luojia Liu,Qiaoling Wang et al. Xiaoqiang Liu et al.
Skin cutaneous melanoma (SKCM), the most aggressive form of cutaneous malignancy globally, remains poorly understood in terms of its molecular drivers. Although the copper metabolism MURR1 domain (COMMD) protein family has been associated w...
Satadeepa Kal,Suborno Jati,Kechun Tang et al. Satadeepa Kal et al.
These findings identify CST as a promising therapeutic prototype for mitigating melanoma progression and overcoming resistance to targeted therapy.
Shankar Suman,Liyi Geng,Wendy K Nevala et al. Shankar Suman et al.
Hierarchical clustering with postoperative samples demonstrated 9 upregulated and 2 downregulated proteins specific to melanoma sEVs, which are associated with melanoma progression (p < 0.05).
Ana G Perez-Romero,Martha A Aceves Villalvazo,Arcelia Y Figueroa Martínez et al. Ana G Perez-Romero et al.
Background: Systemic inflammation plays a pivotal role in melanoma progression through mechanisms of immune suppression, angiogenesis, and metastatic dissemination.
Abhijit Basu,Vida Farsam,Karmveer Singh et al. Abhijit Basu et al.
Aging constitutes the largest risk factor for melanoma progression. While a contribution of factors secreted from senescent skin fibroblasts to the progression of melanoma has been proposed, the nature of such factors and subsequent underly...
耗时 0.13466 秒,为您在 49055432 条记录里面共找到 1530 篇文章 [XML]